Retatrutide is a new medication (still in development) that holds promise for helping people manage obesity and other related health issues. The latest updates in clinical research, including the TRIUMPH-1 trial, are gathering more data on how different dosage levels impact weight loss and other health outcomes in both overweight and obese individuals.
Retatrutide is a multi-functional peptide drug that acts as an agonist of the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This multifaceted approach enhances satiety, increases energy expenditure, and improves glucose metabolism. The drug is designed as a treatment for obesity, type 2 diabetes, and potentially other related metabolic disorders.
While still in the experimental stages, early clinical trials have shown that Retatrutide may be highly effective in reducing body weight and improving blood sugar levels, heralding it as a potential game-changer.
As of now, there isn’t a standardized Retatrutide dosage chart available for public use, primarily because Retatrutide is still in the research and clinical trial phases. The dosages being studied vary, as researchers are trying to determine the most effective and safe amounts for weight management. In the trials, different dosage levels are being tested to see how they impact weight loss and other health markers.
Learn to Start a Profitable Aesthetics Practice in Just 4-Days!
March 28-31 (only 1 spot left!)
June 6-9
in sunny Scottsdale, AZ
Start your transitioning to aesthetic medicine and learn everything you need to grow a profitable aesthetics practice in just 4-days!
March 28-31 (Only 1 spot left!)
June 6-9
Scottsdale, AZ
*Members preferred price for 4-day accelerated program. Save $3,605! Membership is only $295/yr and can be added during registration.
Researchers did a study that lasted nearly a year with 338 adults who were not diabetic but were overweight or obese. These participants were split into six groups and each group received a different amount of the medicine:
1. 1 mg every week for the whole study
2. 2 mg every week for 4 weeks, then 4 mg every week for the rest of the time
3. 4 mg every week for the whole study
4. Starting with 2 mg per week, moving to 4 mg, and then 8 mg weekly for most of the study
5. 4 mg per week for 4 weeks, then 8 mg weekly for the rest of the study
6. Starting with 2 mg per week, increasing to 4 mg, then 8 mg, with the final dose at 12 mg per week
The study showed that the more medicine participants took, the more weight they lost. For example, those on the lowest dose lost about 8.7% of their weight, while those on the highest dose lost 24.2%.
Every participant taking the highest doses of the medication lost at least 5% of their starting weight. They also had improvements in waist size, blood pressure, blood sugar levels, and other health markers, although there wasn’t an increase in “good” cholesterol.
There is also a bigger ongoing study with over 2,000 people to confirm these results and gather more information, which will continue for about 89 weeks.
It’s too early to be certain, but indications are that Retatrutide represents a potentially pivotal advance in the management of obesity and related disorders. With its unique multi-receptor targeting mechanism, it has the potential to offer significant clinical benefits. However, like all emerging therapies, the pathway to routine clinical use requires a thorough examination of its safety, optimal dosing, and long-term effects.
Again, ongoing studies are working to determine the optimal dosage that provides the best results with minimal side effects. Once these trials are completed and analyzed, they will help determine standardized dosing guidelines for potential future use. Until then, Retatrutide remains in the experimental stage, and its dosage is still under investigation.
Sign up today and expand your knowledge & skills in Botox®, Fillers, Lasers,
Chemical Peels, Microdermabrasion and PRP for Aesthetics!
Disclaimer: The information provided here is for general knowledge only and should not be considered medical advice. For any questions or concerns about your health or medications, please consult your physician or healthcare provider. They are best equipped to provide guidance specific to your medical needs.
Attend the most comprehensive accredited AMA PRA CAT 1 CME Botox® training weekend, learn how to create a profitable practice with the top 5 most lucrative non-invasive treatments, get hands-on Botox® training in a multi-million dollar aesthetics practice and get trained in GLP-1 agonists and other medically-supervised weight loss treatments.
Scottsdale, Arizona
Talk with a program advisor to discuss your hands-on or online training options for Botox®, Aesthetic Medicine and Medical Weight Management (GLP-1 inhibitors, semaglutide, tirzepatide and more).
The IAPAM has been helping physicians, nurse practitioners and physician assistants make more & work less with AMA PRA CAT 1 CME certification & training in Botox®, Aesthetic Medicine and Medical Weight Management since 2006.
Choose from online or hands-on training today!
